BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC)

CUSIP: 088786108

Q4 2020 13F Holders as of 31 Dec 2020

Security type / class
Equity / American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share
Total 13F shares
7,328,435
Total 13F value
$131,544,000
Holder snapshot 6 signals
Share change
-221,505
SEC-reported price per share
$17.95
Number of holders
27
Value change
-$3,975,466
Number of buys
16
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
50,340,741

Security key

088786108

Report period

Q4 2020

Institutions

27

Top holders

10

BCYC full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2021 Previous quarter: Q3 2020 BICYCLE THERAPEUTICS PLC SEC filings BICYCLE THERAPEUTICS PLC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TYBOURNE CAPITAL MANAGEME...
Disclosed value leader
TYBOURNE CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F Lead comparable stake: 3.9% Showing 1-6 of 15 holder rows.

Quick read

TYBOURNE CAPITAL MANAGEMENT (HK) LTD leads the comparable SEC ownership view at 3.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TYBOURNE CAPITAL MANAGEMENT (HK) LTD's linked filing trail.
Comparable ownership Top 5
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3.9%
SV Health Investors, LLC 3.8%
Point72 Asset Management, L.P. 2.7%
Atlas Venture Advisors, Inc. 2.6%
SAMLYN CAPITAL, LLC 0.83%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
13F
Company
13F
3.9%
$37,299,000
1,957,961 shares
 — 30 Sep 2020
SV Health Investors, LLC
13F
Company
13F
3.8%
$36,486,000
1,915,274 shares
 — 30 Sep 2020
Point72 Asset Management, L.P.
13F
Company
13F
2.7%
$25,968,000
1,363,151 shares
 — 30 Sep 2020
Atlas Venture Advisors, Inc.
13F
Company
13F
2.6%
$24,898,000
1,306,965 shares
 — 30 Sep 2020
SAMLYN CAPITAL, LLC
13F
Company
13F
0.83%
$7,972,000
418,482 shares
 — 30 Sep 2020
FMR LLC
13F
Company
13F
0.42%
$4,028,000
211,444 shares
 — 30 Sep 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
27
Shares
7,328,435
Rows available
27
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
18
Q4 2020 holders
27
Holder diff
9
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 value Q4 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .